40 related articles for article (PubMed ID: 3170992)
1. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.
Bousquet J; Maasch H; Martinot B; Hejjaoui A; Wahl R; Michel FB
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):439-46. PubMed ID: 3170992
[TBL] [Abstract][Full Text] [Related]
2. A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects.
Hjalmarsson E; Hellkvist L; Karlsson A; Winquist O; Kumlien Georén S; Westin U; Cardell LO
J Investig Allergol Clin Immunol; 2023 Oct; 33(5):362-372. PubMed ID: 37843385
[TBL] [Abstract][Full Text] [Related]
3. Allergenicity, immunogenicity and dose-relationship of three intact allergen vaccines and four allergoid vaccines for subcutaneous grass pollen immunotherapy.
Henmar H; Lund G; Lund L; Petersen A; Würtzen PA
Clin Exp Immunol; 2008 Sep; 153(3):316-23. PubMed ID: 18647321
[TBL] [Abstract][Full Text] [Related]
4. Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study.
Radcliffe MJ; Lewith GT; Turner RG; Prescott P; Church MK; Holgate ST
BMJ; 2003 Aug; 327(7409):251-4. PubMed ID: 12896934
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy.
Starchenka S; Oluwayi K; Heath M; Armfield O; Shamji M; Layhadi J; Lis K; Cadavez L; Rusyn O; Skinner M; De Kam PJ
Clin Exp Allergy; 2024 Feb; 54(2):130-142. PubMed ID: 38169056
[TBL] [Abstract][Full Text] [Related]
6. Response to Correspondence to "Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy".
de Kam PJ; Zielen S; Bernstein JA; Berger U; Berger M; Cuevas M; Cypcar D; Fuhr-Horst A; Greisner WA; Jandl M; Laßmann S; Worm M; Matz J; Sher E; Smith C; Steven GC; Mösges R; Shamji MH; DuBuske L; Borghese F; Oluwayi K; Zwingers T; Seybold M; Armfield O; Heath MD; Hewings SJ; Kramer MF; Skinner MA
Allergy; 2024 Jun; 79(6):1637-1638. PubMed ID: 38525846
[No Abstract] [Full Text] [Related]
7. T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy.
Reithofer M; Boell SL; Kitzmueller C; Horak F; Bohle B; Jahn-Schmid B
Heliyon; 2023 Nov; 9(11):e21878. PubMed ID: 38034768
[TBL] [Abstract][Full Text] [Related]
8. Allergen Immunotherapy: Biomarkers and Clinical Outcome Measures.
Pitsios C
J Asthma Allergy; 2021; 14():141-148. PubMed ID: 33633455
[TBL] [Abstract][Full Text] [Related]
9. The skin prick test response after allergen immunotherapy in different levels of tIgE children with mite sensitive Asthma/Rhinitis in South China.
Sun W; Pan L; Yu Q; Sun Y; Zeng X; Bai X; Li M
Hum Vaccin Immunother; 2018; 14(10):2510-2515. PubMed ID: 30047819
[TBL] [Abstract][Full Text] [Related]
10. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.
Calderon MA; Demoly P; Casale T; Akdis CA; Bachert C; Bewick M; Bilò BM; Bohle B; Bonini S; Bush A; Caimmi DP; Canonica GW; Cardona V; Chiriac AM; Cox L; Custovic A; De Blay F; Devillier P; Didier A; Di Lorenzo G; Du Toit G; Durham SR; Eng P; Fiocchi A; Fox AT; van Wijk RG; Gomez RM; Haathela T; Halken S; Hellings PW; Jacobsen L; Just J; Tanno LK; Kleine-Tebbe J; Klimek L; Knol EF; Kuna P; Larenas-Linnemann DE; Linneberg A; Matricardi M; Malling HJ; Moesges R; Mullol J; Muraro A; Papadopoulos N; Passalacqua G; Pastorello E; Pfaar O; Price D; Del Rio PR; Ruëff R; Samolinski B; Scadding GK; Senti G; Shamji MH; Sheikh A; Sisul JC; Sole D; Sturm GJ; Tabar A; Van Ree R; Ventura MT; Vidal C; Varga EM; Worm M; Zuberbier T; Bousquet J
Clin Transl Allergy; 2016; 6():41. PubMed ID: 27895895
[TBL] [Abstract][Full Text] [Related]
11. A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study.
Pfaar O; van Twuijver E; Boot JD; Opstelten DJ; Klimek L; van Ree R; Diamant Z; Kuna P; Panzner P
Allergy; 2016 Jan; 71(1):99-107. PubMed ID: 26417901
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens.
Akdis CA; Akdis M
World Allergy Organ J; 2015; 8(1):17. PubMed ID: 26023323
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.
Prickett SR; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2015 Jun; 45(6):1015-26. PubMed ID: 25900315
[TBL] [Abstract][Full Text] [Related]
14. A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations.
Klimek L; Sperl A; van Twuijver E; van Ree R; Kleinjans H; Boot JD; Pfaar O
Clin Transl Allergy; 2014; 4():23. PubMed ID: 25097754
[TBL] [Abstract][Full Text] [Related]
15. Sub-lingual immunotherapy: world allergy organization position paper 2009.
Canonica GW; Bousquet J; Casale T; Lockey RF; Baena-Cagnani CE; Pawankar R; Potter PC; Bousquet PJ; Cox LS; Durham SR; Nelson HS; Passalacqua G; Ryan DP; Brozek JL; Compalati E; Dahl R; Delgado L; van Wijk RG; Gower RG; Ledford DK; Filho NR; Valovirta EJ; Yusuf OM; Zuberbier T
World Allergy Organ J; 2009 Nov; 2(11):233-81. PubMed ID: 23268425
[No Abstract] [Full Text] [Related]
16. Actual therapeutic management of allergic and hyperreactive nasal disorders.
Rudack C
GMS Curr Top Otorhinolaryngol Head Neck Surg; 2004; 3():Doc04. PubMed ID: 22073046
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmatics.
Scichilone N; Minaldi C; Santagata R; Battaglia S; Camarda G; Bellia V
J Asthma Allergy; 2011; 4():19-25. PubMed ID: 21660177
[TBL] [Abstract][Full Text] [Related]
18. Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.
Rosewich M; Schulze J; Eickmeier O; Telles T; Rose MA; Schubert R; Zielen S
Clin Exp Immunol; 2010 Jun; 160(3):403-10. PubMed ID: 20345983
[TBL] [Abstract][Full Text] [Related]
19. Allergen injection immunotherapy for seasonal allergic rhinitis.
Calderon MA; Alves B; Jacobson M; Hurwitz B; Sheikh A; Durham S
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001936. PubMed ID: 17253469
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for allergic diseases.
Portnoy JM
Clin Rev Allergy Immunol; 2001 Oct; 21(2-3):241-59. PubMed ID: 11725607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
